135 related articles for article (PubMed ID: 21242584)
1. Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma.
Garcia-Martin E; Gil-Arribas LM; Idoipe M; Alfaro J; Pueyo V; Pablo LE; Fernandez FJ
Br J Ophthalmol; 2011 Oct; 95(10):1393-6. PubMed ID: 21242584
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas.
Garcia-Martin E; Idoipe M; Gil LM; Pueyo V; Alfaro J; Pablo LE; Zubiri ML; Fernandez J
J Ocul Pharmacol Ther; 2010 Aug; 26(4):373-9. PubMed ID: 20698800
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma.
Blasi MA; Giammaria D; Balestrazzi E
Am J Ophthalmol; 2005 Dec; 140(6):1136-9. PubMed ID: 16376667
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod in the treatment of eyelid basal cell carcinoma.
Leppälä J; Kaarniranta K; Uusitalo H; Kontkanen M
Acta Ophthalmol Scand; 2007 Aug; 85(5):566-8. PubMed ID: 17376190
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod 5% cream for the treatment of periocular Basal cell carcinoma.
Carneiro RC; de Macedo EM; Matayoshi S
Ophthalmic Plast Reconstr Surg; 2010; 26(2):100-2. PubMed ID: 20305508
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial.
de Macedo EM; Carneiro RC; de Lima PP; Silva BG; Matayoshi S
BMC Ophthalmol; 2015 Apr; 15():35. PubMed ID: 25885553
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area.
Karabulut GO; Kaynak P; Ozturker C; Fazil K; Ocak OB; Taskapılı M
Indian J Ophthalmol; 2017 Jan; 65(1):48-51. PubMed ID: 28300740
[TBL] [Abstract][Full Text] [Related]
8. Topical imiquimod 5% as an alternative therapy in periocular basal cell carcinoma in two patients with surgical contraindication.
Costales-Álvarez C; Álvarez-Coronado M; Rozas-Reyes P; González-Rodríguez CM; Fernández-Vega L
Arch Soc Esp Oftalmol; 2017 Feb; 92(2):93-96. PubMed ID: 27601079
[TBL] [Abstract][Full Text] [Related]
9. Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up.
Schiessl C; Wolber C; Tauber M; Offner F; Strohal R
J Drugs Dermatol; 2007 May; 6(5):507-13. PubMed ID: 17679185
[TBL] [Abstract][Full Text] [Related]
10. Treatment of basal cell carcinoma of the eyelids with 5% topical imiquimod: a 3-year follow-up study.
Choontanom R; Thanos S; Busse H; Stupp T
Graefes Arch Clin Exp Ophthalmol; 2007 Aug; 245(8):1217-20. PubMed ID: 17345092
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome after treatment with 5% topical imiquimod cream in patients with basal cell carcinoma of the eyelids.
Prokosch V; Thanos S; Spaniol K; Stupp T
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):121-5. PubMed ID: 20886224
[TBL] [Abstract][Full Text] [Related]
12. The use of imiquimod in the treatment of periocular tumours.
Ross AH; Kennedy CT; Collins C; Harrad RA
Orbit; 2010 Apr; 29(2):83-7. PubMed ID: 20394545
[TBL] [Abstract][Full Text] [Related]
13. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion.
Sterry W; Ruzicka T; Herrera E; Takwale A; Bichel J; Andres K; Ding L; Thissen MR
Br J Dermatol; 2002 Dec; 147(6):1227-36. PubMed ID: 12452875
[TBL] [Abstract][Full Text] [Related]
14. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
Vidal D; Matías-Guiu X; Alomar A
Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
[TBL] [Abstract][Full Text] [Related]
15. Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial.
Peris K; Campione E; Micantonio T; Marulli GC; Fargnoli MC; Chimenti S
Dermatol Surg; 2005 Mar; 31(3):318-23. PubMed ID: 15841634
[TBL] [Abstract][Full Text] [Related]
16. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
Schulze HJ; Cribier B; Requena L; Reifenberger J; Ferrándiz C; Garcia Diez A; Tebbs V; McRae S
Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150
[TBL] [Abstract][Full Text] [Related]
17. Imiquimod 5% cream as an adjuvant pre-operative treatment for basal cell carcinoma of the periocular area.
Bonilla R; Solebo AL; Khandwala MA; Jones CA
Orbit; 2014 Dec; 33(6):471-3. PubMed ID: 25255050
[TBL] [Abstract][Full Text] [Related]
18. Vismodegib for periocular and orbital basal cell carcinoma.
Gill HS; Moscato EE; Chang AL; Soon S; Silkiss RZ
JAMA Ophthalmol; 2013 Dec; 131(12):1591-4. PubMed ID: 24136169
[TBL] [Abstract][Full Text] [Related]
19. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
Neville JA; Williford PM; Jorizzo JL
J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens.
Shumack S; Robinson J; Kossard S; Golitz L; Greenway H; Schroeter A; Andres K; Amies M; Owens M
Arch Dermatol; 2002 Sep; 138(9):1165-71. PubMed ID: 12224977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]